During the last session, Rapid Micro Biosystems Inc (NASDAQ:RPID)’s traded shares were 1.05 million, with the beta value of the company hitting 1.21. At the end of the trading day, the stock’s price was $3.57, reflecting an intraday gain of 9.51% or $0.31. The 52-week high for the RPID share is $3.30, that puts it up 7.56 from that peak though still a striking 83.75% gain since the share price plummeted to a 52-week low of $0.58. The company’s market capitalization is $153.63M, and the average trade volume was 199.16K shares over the past three months.
Rapid Micro Biosystems Inc (RPID) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. RPID has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.22.
Rapid Micro Biosystems Inc (NASDAQ:RPID) trade information
Rapid Micro Biosystems Inc (RPID) registered a 9.51% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.51% in intraday trading to $3.57, hitting a weekly high. The stock’s 5-day price performance is 15.16%, and it has moved by 227.52% in 30 days. Based on these gigs, the overall price performance for the year is 268.04%.
The consensus price target of analysts on Wall Street is $8, which implies an increase of 55.38% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8 and $8 respectively. As a result, RPID is trading at a discount of -124.09% off the target high and -124.09% off the low.
Rapid Micro Biosystems Inc (RPID) estimates and forecasts
In the rating firms’ projections, revenue will increase 24.78% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 8.2M as predicted by 1 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 6.6M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 6.34M and 5.61M respectively. In this case, analysts expect current quarter sales to grow by 29.40% and then jump by 17.63% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -16.10%. While earnings are projected to return 11.20% in 2025, the next five years will return 12.40% per annum.
RPID Dividends
Rapid Micro Biosystems Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.94 million shares, is of KENNEDY LEWIS MANAGEMENT LP’s that is approximately 11.4229% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.26 million.
